These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 12860340)
1. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Fiala C; Safar P; Bygdeman M; Gemzell-Danielsson K Eur J Obstet Gynecol Reprod Biol; 2003 Aug; 109(2):190-5. PubMed ID: 12860340 [TBL] [Abstract][Full Text] [Related]
2. Feasibility and effectiveness of unintended pregnancy prevention with low-dose mifepristone combined with misoprostol before expected menstruation. Li CL; Chen DJ; Deng YF; Song LP; Mo XT; Liu KJ Hum Reprod; 2015 Dec; 30(12):2794-801. PubMed ID: 26405260 [TBL] [Abstract][Full Text] [Related]
3. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol. Haimov-Kochman R; Arbel R; Sciaky-Tamir Y; Brzezinski A; Laufer N; Yagel S Acta Obstet Gynecol Scand; 2007; 86(4):462-6. PubMed ID: 17486469 [TBL] [Abstract][Full Text] [Related]
4. Medical abortion in the first trimester: the use of serum hCG and endometrial thickness as markers of completeness. Parashar P; Iversen OE; Midbøe G; Myking O; Bjørge L Eur J Contracept Reprod Health Care; 2007 Dec; 12(4):366-71. PubMed ID: 17853164 [TBL] [Abstract][Full Text] [Related]
6. Medical management of unwanted pregnancy in France: modalities and outcomes. The aMaYa study. Nisand I; Bettahar K; Eur J Obstet Gynecol Reprod Biol; 2015 Jan; 184():13-8. PubMed ID: 25462213 [TBL] [Abstract][Full Text] [Related]
7. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Honkanen H; Ranta S; Ylikorkala O; Heikinheimo O Hum Reprod; 2002 Sep; 17(9):2315-9. PubMed ID: 12202418 [TBL] [Abstract][Full Text] [Related]
8. Serum hCG threshold to assess medical abortion success. Le Lous M; Gallinand AC; Laviolle B; Peltier L; Nyangoh Timoh K; Lavoué V Eur J Contracept Reprod Health Care; 2018 Dec; 23(6):458-463. PubMed ID: 30601107 [TBL] [Abstract][Full Text] [Related]
9. Feasibility of self-performed urine pregnancy testing for follow-up after medical abortion. Hassoun D; Périn I; Hiên H; Demars HH Eur J Obstet Gynecol Reprod Biol; 2016 Feb; 197():174-8. PubMed ID: 26773308 [TBL] [Abstract][Full Text] [Related]
10. Serum human chorionic gonadotropin (hCG) trend within the first few days after medical abortion: a prospective study. Pocius KD; Bartz D; Maurer R; Stenquist A; Fortin J; Goldberg AB Contraception; 2017 Mar; 95(3):263-268. PubMed ID: 27621046 [TBL] [Abstract][Full Text] [Related]
11. Termination of early pregnancy in the scarred uterus with mifepristone and misoprostol. Xu J; Chen H; Ma T; Wu X Int J Gynaecol Obstet; 2001 Mar; 72(3):245-51. PubMed ID: 11226445 [TBL] [Abstract][Full Text] [Related]
12. Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol [corrected]. Aubény E; Peyron R; Turpin CL; Renault M; Targosz V; Silvestre L; Ulmann A; Baulieu EE Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():85-91. PubMed ID: 8574255 [TBL] [Abstract][Full Text] [Related]
13. Monitoring medical abortion using mifepristone/misoprostol combination with ultrasonogram and serum human chorionic gonadotropin. Chou SY; Chen CY; Chiang HK; Chow PK; Wang CC; Hsu CS Taiwan J Obstet Gynecol; 2006 Mar; 45(1):48-52. PubMed ID: 17272208 [TBL] [Abstract][Full Text] [Related]
14. A cross-sectional analysis of mifepristone, misoprostol, and combination mifepristone-misoprostol package inserts obtained in 20 countries. Frye LJ; Kilfedder C; Blum J; Winikoff B Contraception; 2020 May; 101(5):315-320. PubMed ID: 32032639 [TBL] [Abstract][Full Text] [Related]
15. Follow-up strategies to confirm the success of medical abortion of pregnancies up to 10 weeks' gestation: a systematic review with meta-analyses. Schmidt-Hansen M; Cameron S; Lohr PA; Hasler E Am J Obstet Gynecol; 2020 Jun; 222(6):551-563.e13. PubMed ID: 31715147 [TBL] [Abstract][Full Text] [Related]
16. [Termination of pregnancy in the 2nd trimester: mifepriston/misoprostol preferable to sulprostone]. Ebbers S; Creemers JW; Lotgering FK Ned Tijdschr Geneeskd; 2009; 153():A138. PubMed ID: 19930731 [TBL] [Abstract][Full Text] [Related]
17. Timing and indication for curettage after medical abortion in early pregnant women with prior uterine incision. Wang G; Li D; Manconi F; Dong B; Zhang Y; Sun B Contraception; 2010 Jan; 81(1):62-6. PubMed ID: 20004275 [TBL] [Abstract][Full Text] [Related]
18. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: A randomized trial. Schaff EA; Fielding SL; Westhoff C; Ellertson C; Eisinger SH; Stadalius LS; Fuller L JAMA; 2000 Oct; 284(15):1948-53. PubMed ID: 11035891 [TBL] [Abstract][Full Text] [Related]
19. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol. Guest J; Chien PF; Thomson MA; Kosseim ML BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893 [TBL] [Abstract][Full Text] [Related]
20. Early serum human chorionic gonadotropin (hCG) trends after medication abortion. Pocius KD; Maurer R; Fortin J; Goldberg AB; Bartz D Contraception; 2015 Jun; 91(6):503-6. PubMed ID: 25765358 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]